Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: Was mycophenolate the cause? (Nephrology Dialysis Transplantation (2008) DOI: 10.1093/ndt/gfn194);Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: Was mycophenolate the cause?

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2409-2411

  Jahromi A , Hamidian ^a,d   Roberts, Ian S D ^b   Winearls, Chris G ^c   Vaidya, Anil ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Hyperoxalosis; Mycophenolate mofetil; Pancreas and kidney; Renal failure

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DIALYSIS; DIARRHEA; DRUG SUBSTITUTION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPEROXALURIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT; KIDNEY PANCREAS TRANSPLANTATION; MALABSORPTION; MALE; OXALOSIS; PRIORITY JOURNAL;

EID: 46849100837     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn647     Document Type: Erratum

References (9)

1. Samaniego M, Becker BN, Djamali A. Drug insight: maintenance immunosuppression in kidney transplant recipients. Nat Clin Prac Nephrol 2006; 2: 688-699
2. Kamar N, Faure P, Dupuis E et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transplant Int 2004; 17: 463-467
3. Hoppe B, Leumann E, von Unruh G et al. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 2003; 1: 437-443
4. Alsuwaida A, Hayat A, Alwakeel JS. Oxalosis presenting as early renal allograft failure. Saudi J Kidney Dis Transpl 2007; 18: 253-256
5. Heer MK, Sharma A, Joshi K et al. Early allograft failure in an unrecognized case of primary hyperoxalosis. Nephrology (Carlton) 2005; 10: 423-424
6. Tang IY, Meier-Kriesche HU, Kaplan B. Immunosuppressive strategies to improve outcome of kidney transplantation. Semin Nephrol 2007; 27: 377-392
7. Guerard A, Rabodonorina M, Cotte L et al. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation 1999; 68: 699-707
8. Maes BD, Dalle I, Geboes K et al. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation 2003; 75: 665-672
9. Ferraz RR, Tiselius HG, Heilberg IP. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion. Kidney Int 2004; 66: 676-682